{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:46:54Z","timestamp":1761929214866},"reference-count":17,"publisher":"Informa UK Limited","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1080\/00365540310017023","type":"journal-article","created":{"date-parts":[[2004,4,30]],"date-time":"2004-04-30T03:08:06Z","timestamp":1083294486000},"page":"826-829","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of Leishmania chagasi DNA Topoisomerase II: a Potential Chemotherapeutic Target"],"prefix":"10.1080","volume":"35","author":[{"given":"Jacira M.A.","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Lareau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma M.B.","family":"Jeronimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11908-999-0057-8","volume":"1","author":"Pearson RD","year":"1999","journal-title":"Leishmaniasis at the end of the millennium. Curr Infect Dis Rep"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0035-9203(94)90393-X","volume":"88","author":"SMB Jer\u00f4nimo","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"Sundar S","year":"2001","journal-title":"Trop Med Int Health"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1146\/annurev.bi.50.070181.004311","volume":"50","author":"Gellert M","year":"1981","journal-title":"Ann Rev Biochem"},{"key":"CIT0005","first-page":"12","volume":"82","author":"Hooper DC","year":"1987","journal-title":"Am J Med"},{"key":"CIT0006","first-page":"4173","volume":"264","author":"Shapiro TA","year":"1989","journal-title":"Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria. J Biol Chem"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1073\/pnas.87.3.950","volume":"87","author":"Shapiro TA","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CIT0008","first-page":"2973","volume":"264","author":"Shen LL","year":"1989","journal-title":"Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.36.2.495","volume":"36","author":"Werbovetz KA","year":"1992","journal-title":"Antimicrob Agents Chem"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(94)90110-4","volume":"65","author":"Werbovetz KA","year":"1994","journal-title":"Mol Biochem Parasitol"},{"issue":"7539","key":"CIT0011","first-page":"44","volume":"24","author":"Bodley AL","year":"2003","journal-title":"An unusual type IB topoisomerase from African trypanosomes. Proc Natl Acad Sci U S A"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/AAC.40.3.706","volume":"40","author":"Slunt KM","year":"1996","journal-title":"Antimicrob Agent Chem"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/jm970232h","volume":"40","author":"Gamage SA","year":"1997","journal-title":"J Med Chem"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-4758(00)01697-5","volume":"16","author":"Cheesman SJ","year":"2000","journal-title":"Parasitol Today"},{"key":"CIT0015","first-page":"1844","volume":"29","author":"Das A","year":"2001","journal-title":"Characterization of the gene encoding type II DNA topoisomerase from Leishmania donovani. A key molecular target in antileishmanial therapy. Nucleic Acids Res"},{"key":"CIT0016","first-page":"123","volume":"21","author":"Kelly JM","year":"1993","journal-title":"Methods Mol Biol"},{"key":"CIT0017","first-page":"4673","volume":"22","author":"Thompson JD","year":"1994","journal-title":"Gibson TJ. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res"}],"container-title":["Scandinavian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365540310017023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T23:11:56Z","timestamp":1585782716000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365540310017023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":17,"journal-issue":{"issue":"11-12","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1080\/00365540310017023"],"URL":"https:\/\/doi.org\/10.1080\/00365540310017023","relation":{},"ISSN":["0036-5548","1651-1980"],"issn-type":[{"value":"0036-5548","type":"print"},{"value":"1651-1980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}